XWELL, Inc. logo

XWELL, Inc.

XWEL

NASDAQConsumer CyclicalPersonal Products & Services

Previous close

$1.04

+$0.1099 · +11.82%

Aug 21, 4:00 PM ET

XWEL company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

82

Deep Value

Momentum

30

Weakening

Sentiment

49

Mixed

Risk resilience

28

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

XWELL Inc. functions as a health and wellness services provider, primarily operating within airports. The company delivers its diverse offerings through various brands, including XpresSpa, XpresTest, Treat, and HyperPointe. Its core services feature a range of spa treatments such as massages, nail care, and skincare, further complemented by the sale of spa, travel, and general retail merchandise. Beyond relaxation services, XWELL also manages dedicated wellness centers. These facilities provide crucial health diagnostic services, encompassing COVID-19 screening and testing, rapid tests for various communicable diseases like influenza, RSV, and different flu strains (A&B), alongside seasonal flu vaccinations and other medical diagnostic procedures. To enhance accessibility for the traveling public, the company utilizes an integrated digital platform and a tailored retail selection. As of December 31, 2021, XWELL maintained a significant global presence, with 52 spa and clinic locations spanning 24 airports across the United States, the Netherlands, and the United Arab Emirates. The organization, headquartered in New York, New York, underwent a name change in October 2022, transitioning from its former identity as XpresSpa Group, Inc. to its current designation, XWELL Inc.

Industry
Personal Products & Services
Sector
Consumer Cyclical
Headquarters
US
CEO
Ezra T. Ernst
Listed since
Jul 27, 2010
Employees
175

Market position

Day range

Current $1.04

52-week range

Current $1.04

Open
$0.9871
Previous close
$0.9301
Volume
108.17K
0.92× average
Average volume
117.16K
Average daily volume
Market cap
8.24M USD
Beta
1.01
Market reference 1
50-day average
$1.0502
-0.97% below average
200-day average
$0.9679
+7.45% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
11.41M USD
P/E (TTM)
-0.2×
P/B (TTM)
-4.46×
P/S (TTM)
0.29×
EV / EBITDA
-0.81×
Earnings yield
-1104.35%
Free cash flow yield
-758.96%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
30.69%
Operating margin
-24.14%
Net margin
-82.81%
Return on equity
77.10%
Return on assets
-151.48%
Return on invested capital
-247.71%

Financial health

Debt / equity
-3.93×
Current ratio
0.46×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends58%3%-52%-107%Gross margin, FY2021: 43.87%Gross margin, FY2022: 21.54%Gross margin, FY2023: 12.23%Gross margin, FY2024: 26.31%Gross margin, FY2025: 22.75%Operating margin, FY2021: 5.57%Operating margin, FY2022: -55.71%Operating margin, FY2023: -93.68%Operating margin, FY2024: -49.29%Operating margin, FY2025: -32.03%Net margin, FY2021: 4.54%Net margin, FY2022: -58.70%Net margin, FY2023: -92.14%Net margin, FY2024: -49.72%Net margin, FY2025: -58.17%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 43.87%. Gross margin FY2022 21.54%. Gross margin FY2023 12.23%. Gross margin FY2024 26.31%. Gross margin FY2025 22.75%. Operating margin FY2021 5.57%. Operating margin FY2022 -55.71%. Operating margin FY2023 -93.68%. Operating margin FY2024 -49.29%. Operating margin FY2025 -32.03%. Net margin FY2021 4.54%. Net margin FY2022 -58.70%. Net margin FY2023 -92.14%. Net margin FY2024 -49.72%. Net margin FY2025 -58.17%.

Income trends

Revenue

29.21M USD-13.83%

Operating income

−9.36M USD+44.00%

Net income

−16.99M USD-0.82%
Income trends across reported periods84.39M USD41.76M USD−867.2K USD−43.49M USDRevenue, FY2021: 73.73M USDRevenue, FY2022: 55.94M USDRevenue, FY2023: 30.11M USDRevenue, FY2024: 33.9M USDRevenue, FY2025: 29.21M USDOperating income, FY2021: 4.11M USDOperating income, FY2022: −31.16M USDOperating income, FY2023: −28.21M USDOperating income, FY2024: −16.71M USDOperating income, FY2025: −9.36M USDNet income, FY2021: 3.35M USDNet income, FY2022: −32.84M USDNet income, FY2023: −27.74M USDNet income, FY2024: −16.85M USDNet income, FY2025: −16.99M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 73.73M USD. Revenue FY2022 55.94M USD. Revenue FY2023 30.11M USD. Revenue FY2024 33.9M USD. Revenue FY2025 29.21M USD. Operating income FY2021 4.11M USD. Operating income FY2022 −31.16M USD. Operating income FY2023 −28.21M USD. Operating income FY2024 −16.71M USD. Operating income FY2025 −9.36M USD. Net income FY2021 3.35M USD. Net income FY2022 −32.84M USD. Net income FY2023 −27.74M USD. Net income FY2024 −16.85M USD. Net income FY2025 −16.99M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue29.21M USD33.9M USD30.11M USD55.94M USD73.73M USD
Cost of goods sold22.57M USD24.98M USD26.43M USD43.89M USD41.39M USD
Gross profit6.64M USD8.92M USD3.68M USD12.05M USD32.34M USD
Selling, general, and administrative16M USD20.08M USD20.91M USD31.17M USD24.2M USD
Operating expenses16M USD25.63M USD31.89M USD43.21M USD28.24M USD
Interest income661K USD380K USD448K USD384K USD
Interest expense134K USD179K USD321K USD462K USD
Depreciation and amortization1.78M USD938K USD3.55M USD5.43M USD3.2M USD
Operating income−9.36M USD−16.71M USD−28.21M USD−31.16M USD4.11M USD
Net income−16.99M USD−16.85M USD−27.74M USD−32.84M USD3.35M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
29%
2 beats, 4 misses, 1 met estimate
Average EPS surprise
-44.49%
7 comparable reports
Latest EPS result
-0.26
Estimate -1 · Beat by 74.00%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates-0.22-1.31-2.41-3.5Q4 '24No estimateQ2 '25MissQ3 '25No estimateQ4 '25No estimateQ2 '26MissQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q4 2024, reported Nov 14, 2024: actual -0.99, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 20, 2025: actual -1, estimate -0.82, surprise -21.95%, Miss. Q3 2025, reported Aug 14, 2025: actual -0.56, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual -0.26, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Apr 1, 2026: actual -3.26, estimate -1, surprise -226.00%, Miss. Q2 2026, reported May 20, 2026: actual -1.51, estimate -1, surprise -51.00%, Miss. Q3 2026, reported Aug 14, 2026: actual -0.26, estimate -1, surprise +74.00%, Beat. Q4 2026, reported Nov 18, 2026: actual —, estimate -0.6, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates9.31M6.88M4.45M2.02MQ4 '24No estimateQ2 '25MissQ3 '25No estimateQ4 '25No estimateQ2 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q4 2024, reported Nov 14, 2024: actual 8.42M USD, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 20, 2025: actual 7.02M USD, estimate 8.8M USD, surprise -20.19%, Miss. Q3 2025, reported Aug 14, 2025: actual 7.69M USD, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 14, 2025: actual 7.35M USD, estimate —, surprise —, Comparison unavailable. Q2 2026, reported Apr 1, 2026: actual 7.15M USD, estimate 2.37M USD, surprise +201.69%, Beat. Q2 2026, reported May 20, 2026: actual 6.64M USD, estimate 2.37M USD, surprise +179.97%, Beat. Q3 2026, reported Aug 14, 2026: actual 7.15M USD, estimate 2.37M USD, surprise +201.39%, Beat. Q4 2026, reported Nov 18, 2026: actual —, estimate 6.87M USD, surprise —, Comparison unavailable.

XWEL peers

ETFs holding XWEL

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research XWEL

research.disclaimer